Showing all 2 results
Lamivudine, Zidovudine & Nevirapine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (often White or Off-White). This FDC is designed for patients who have successfully completed the Nevirapine “lead-in” phase.
Active Ingredient Strength (Standard) Class Lamivudine USP/BP 150 mg NRTI (Cytidine Analog) Zidovudine USP/BP 300 mg NRTI (Thymidine Analog) Nevirapine USP/BP 200 mg NNRTI Excipients Q.S. Microcrystalline Cellulose / Sodium Starch Glycolate Tenofovir, Lamivudine & Dolutegravir Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Film-Coated Tablet, packed strictly in heavy-gauge HDPE bottles with integrated silica gel desiccants. This packaging is absolutely non-negotiable, as Tenofovir is highly susceptible to hydrolytic degradation in humid environments.
Active Ingredient Strength Primary Clinical Function Tenofovir Disoproxil Fumarate (TDF) INN/Ph.Eur. 300 mg Potent Nucleotide Reverse Transcriptase Inhibitor (NRTI). Lamivudine (3TC) INN/Ph.Eur. 300 mg Synergistic Nucleoside Reverse Transcriptase Inhibitor (NRTI). Dolutegravir (DTG) INN/Ph.Eur. 50 mg Advanced Integrase Strand Transfer Inhibitor (INSTI). Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Staryl Fumarate Diluent / Superdisintegrant / Lubricant (Engineered for uniform FDC dissolution)
